Dr. Bever

Christopher T. Bever, M. D.

Christopher T. Bever, M. D.

Dr. Christopher Bever is a Professsor of Neurology with the Department of Neurology, University of Maryland Medical School and Chief of the Neurology Service at the VA Medical Center in Baltimore. He is Director of the VA Multiple Sclerosis Center of Excellence, East, one of only two such centers in the Veterans Affairs Medical System. He has been with the University of Maryland since 1987.

He has conducted extensive research in symptomatic management of MS with compounds that include 3,4 diaminopyridine and 4-aminopyridine. He is also involved in a research project through the VA Medical System using robotics in patients with arm dysfunction due to hemiparesis. In addition to his research, he has also published numerous articles on many different aspects of MS care.

Dr. Bever sees patients on Tuesday afternoons on the 4th Tuesday of every month at the Neurology Ambulatory Center. Appointments may be made by calling the appointment desk at 410-328-5858.

Administrative Office Address: Patient Appointment Address:
Maryland Center for MS
11 South Paca St., 4th floor
Baltimore, MD 21201
Phone 410-328-5605
Fax 410-328-5425
Neurology Ambulatory Center
16 South Eutaw Street, 3rd floor
Baltimore, MD 21201
Phone 410-328-5858
Fax 410-328-1149

Education and Training:
1971 A.B., Washington University, Saint Louis, Missouri
1975 M.D., University of Rochester, Rochester, New York
1975-1976

Internship, Internal Medicine
University of Cincinnati, Cincinnati, Ohio
1976-1977


Resident, Internal Medicine
Rutgers-College of Medicine and Dentistry of New Jersey
Piscataway, New Jersey
1977-1980


Resident, Neurology
Columbia-Presbyterian Medical Center
New York, New York
1979-1980


Visiting Fellow (Preceptor: Audrey S. Penn, M.D.), Department of Neurology, College of Physicians and Surgeons of Columbia University
New York, New York
1980-1982

Research Associate (Preceptor: Richard Asofsky
National Institutes of Health, Bethesda, MD
1982-1984


Senior Staff Fellow (Preceptor: Dale E. McFarlin,M.D.)
Neuroimmunology Branch, NINCDS
National Institutes of Health, Bethesda, MD
 
Certifications
1976 National Board of Medical Examiners (# 152658)
1982 1982 American Board of Psychiatry and Neurology (Neurology, Certificate 24303)
2001 Johns Hopkins Business of Medicine, Johns Hopkins University
 
Current Appointments
1992-present Associate Professor (with tenure), Department of Neurology, University of Maryland, Baltimore, MD
1995-present Associate Professor, Department of Pharmacology and Experimental Therapeutics, University of Maryland, Baltimore, MD
1995-present Regular Member, Graduate Student Faculty, University of Maryland Graduate School, Baltimore, MD
1998-present Professor (with tenure), Department of Neurology, University of Maryland, Baltimore, MD
1987-present Staff Neurologist, Neurology Service, Veterans Administration Medical Center, Baltimore, MD
1987-present Staff Neurologist, University of Maryland Hospital, Baltimore, MD
1990-present
Chief, Neurology Service, Department of Veterans Affairs Medical Center, Baltimore, MD

Research Activities

Principal Investigator

  • 4-AP as symptomatic management in MS, Acorda

  • Rebif vs. Copaxone, Serono

  • Development of a Robotic gait trainer

  • Evaluation of a robotic training device in patients with arm hemiparesis.

  • Sub-Investigator

  • Campath versus Rebif in early MS, Ilex Pharmaceuticals

  • Copaxone 20 mg vs. 40 mg, Teva Neuroscience

  • Copaxone in Clinically Isolated Syndrome, Teva Neuroscience

  • Long Term Safety of Copaxone in MS, Teva Neuroscience

  • Avonex in combination with Copaxone in MS, NIH funded

  • Betaseron or Rebif switching to Copaxone or continuing cerrent treatment, Teva Neuroscience

  • Oral Chemokine Antagonist in MS, Merck

  • Anti IL-12 in early MS, Centocor

  • Natalizumab (Antegren) in combination with Avonex, Biogen-Idec

  • Natalizumab (Antegren) in combination with Copaxone, Biogen-Idec

  • ABOVE, Berlex

  • Long term safety of Avonex, Biogen

  • Rituximab in MS, Genentech

  • For more information about the Maryland Center for Multiple Sclerosis, please call 410-328-5605.

    This page was last updated: July 17, 2013

             
    Average rating (5)